Dendritic cell (DC)-specific intercellular adhesion molecule 3 (ICAM-3)-grabbing nonintegrin (DC-SIGN, CD209), a C-type surface lectin in human DCs, is a receptor for Leishmania amastigotes

被引:132
作者
Colmenares, M [1 ]
Puig-Kröger, A [1 ]
Pello, OM [1 ]
Corbí, AL [1 ]
Rivas, L [1 ]
机构
[1] CSIC, Ctr Invest Biol, E-28006 Madrid, Spain
关键词
D O I
10.1074/jbc.M205270200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Dendritic cells (DCs) play a critical role in the initiation of the immunological response against Leishmania parasites. However, the receptors involved in amastigote-dendritic cell interaction are unknown, especially in absence of opsonizing antibodies. We have studied the interaction of Leishmania pifanoi axenic amastigotes with the C-type lectin DC-specific intercellular adhesion molecule (ICAM)-3-grabbing nonintegrin (DC-SIGN, CD209), a receptor for ICAM-2, ICAM-3, human immunodeficiency virus gp120, and Ebola virus. L. pifanoi amastigotes interact with immature human dendritic cells and CD209-transfected K562 cells in a time- and dose-dependent manner. Leishmania amastigote binding to human dendritic cells and DC-SIGN-transfected cells is inhibited by a function-blocking DC-SIGN-specific monoclonal antibody. More importantly, this monoclonal antibody dramatically reduces internalization of Leishmania amastigotes by immature human DCs. These results constitute the first description of a non-viral pathogen ligand for DC-SIGN and provide evidence for a relevant role of DC-SIGN in Leishmania amastigote uptake by dendritic cells. Our finding has important implications for Leishmania host-cell interaction and the immunoregulation of cutaneous leishmaniasis.
引用
收藏
页码:36766 / 36769
页数:4
相关论文
共 36 条
[1]   Dendritic cells and the control of immunity [J].
Banchereau, J ;
Steinman, RM .
NATURE, 1998, 392 (6673) :245-252
[2]   PARASITISM OF EPIDERMAL LANGERHANS CELLS IN EXPERIMENTAL CUTANEOUS LEISHMANIASIS WITH LEISHMANIA-MAJOR [J].
BLANK, C ;
FUCHS, H ;
RAPPERSBERGER, K ;
ROLLINGHOFF, M ;
MOLL, H .
JOURNAL OF INFECTIOUS DISEASES, 1993, 167 (02) :418-425
[3]   Sudanese mucosal leishmaniasis: Epidemiology, clinical features, diagnosis, immune responses and treatment [J].
ElHassan, AM ;
Meredith, SEO ;
Yagi, HI ;
Khalil, EAG ;
Ghalib, HW ;
Abbas, K ;
Zijlstra, EE ;
Kroon, CCM ;
Schoone, GJ ;
Ismail, A .
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 1995, 89 (06) :647-652
[4]   C-type lectin receptors on dendritic cells and Langerhans cells [J].
Figdor, CG ;
van Kooyk, Y ;
Adema, GJ .
NATURE REVIEWS IMMUNOLOGY, 2002, 2 (02) :77-84
[5]   Identification of different binding sites in the dendritic cell-specific receptor DC-SIGN for intercellular adhesion molecule 3 and HIV-1 [J].
Geijtenbeek, TBH ;
van Duijnhoven, GCF ;
van Vliet, SJ ;
Krieger, E ;
Vriend, G ;
Figdor, CG ;
van Kooyk, Y .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (13) :11314-11320
[6]   DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells [J].
Geijtenbeek, TBH ;
Kwon, DS ;
Torensma, R ;
van Vliet, SJ ;
van Duijnhoven, GCF ;
Middel, J ;
Cornelissen, ILMHA ;
Nottet, HSLM ;
KewalRamani, VN ;
Littman, DR ;
Figdor, CG ;
van Kooyk, Y .
CELL, 2000, 100 (05) :587-597
[7]   Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses [J].
Geijtenbeek, TBH ;
Torensma, R ;
van Vliet, SJ ;
van Duijnhoven, GCF ;
Adema, GJ ;
van Kooyk, Y ;
Figdor, CG .
CELL, 2000, 100 (05) :575-585
[8]   DC-SIGN-ICAM-2 interaction mediates dendritic cell trafficking [J].
Geijtenbeek, TBH ;
Krooshoop, DJEB ;
Bleijs, DA ;
van Vliet, SJ ;
van Duijnhoven, GCF ;
Grabovsky, V ;
Alon, R ;
Figdor, CG ;
van Kooyk, Y .
NATURE IMMUNOLOGY, 2000, 1 (04) :353-357
[9]   COMPARISON OF RECEPTORS REQUIRED FOR ENTRY OF LEISHMANIA-MAJOR AMASTIGOTES INTO MACROPHAGES [J].
GUY, RA ;
BELOSEVIC, M .
INFECTION AND IMMUNITY, 1993, 61 (04) :1553-1558
[10]   Function and assembly of the Leishmania surface coat [J].
Ilgoutz, SC ;
McConville, MJ .
INTERNATIONAL JOURNAL FOR PARASITOLOGY, 2001, 31 (09) :899-908